Forge Biologics
The Associate Scientist II, Analytical Development (Protein-Based Assays) at Forge Biologics will lead the execution and optimization of complex protein-based assays for AAV gene therapy products, collaborating with cross‑functional teams to ensure assay quality and consistency. The role offers hands‑on experience in analytical development, contributing to method development, regulatory support, and continuous process improvement.
Headquarters
Columbus, Ohio, United States
Company Size
201-500 employees
Founded
2020
Forge Biologics is a CDMO focused on accelerating gene therapy manufacturing, specializing in high‑yield adeno‑associated virus (AAV) vector production. The company offers end‑to‑end services including process and analytical development, clinical‑to‑commercial cGMP manufacturing at a world‑class facility, and regulatory and supply‑chain support. Clients partner with Forge for scalable AAV capacity, technical expertise, and seamless program support to move therapies faster toward patients.
Forge Biologics Emphasizes Safety Culture and EHSS Leadership
24 hours ago
The Progeria Research Foundation and Forge Biologics Announce Manufacturing Partnership to Advance Gene Therapy for Children with Progeria
1 week ago
May the Forge be with you: Ascidian partners with Forge Biologics to tackle Stargardt disease
Jan 13, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Forge Biologics.
Forge Biologics didn’t post a salary, so this is our estimate from similar listings.
7% below the average for this role
Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment
Jan 7, 2026
Analytical Development Scientist
tcw global
Advisor, Analytical Development - Gene Therapy
Eli Lilly and Company
Senior Associate Scientist – Plate-Based Analytical Assays – Transitional and Early Development
Elanco
Director, Bioassay Development
Denali Therapeutics
Scientist II - Molecular Analytics & NGS
UCB
Scientist II - Molecular Analytics & NGS
UCB